What's Hot

    16 of 23 REIT shares beat Wall Street income views this week: Earnings Scorecard | Invesloan.com

    May 2, 2026

    XRP Price Analysis: Buy Now or Wait for Ripple to Fall Below $1? | Invesloan.com

    May 2, 2026

    ‘We’re all nervous the honey pot will run dry’: Does the U.S. authorities borrow from my Social Security to fund federal packages? | Invesloan.com

    May 2, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » Supreme Court faces emergency request over abortion tablet entry ruling | Invesloan.com
    Politics

    Supreme Court faces emergency request over abortion tablet entry ruling | Invesloan.com

    May 2, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email

    NEWYou can now listen to Fox News articles!

    The legal battle over abortion pills escalated to the Supreme Court on Saturday, as the manufacturer of mifepristone filed an emergency request warning a lower court ruling is already causing “immediate confusion and upheaval” across the country.

    Danco Laboratories is asking the high court to quickly block a 5th U.S. Circuit Court of Appeals decision that blocked mail-order access and reinstated in-person requirements for the drug, arguing the ruling is disrupting access and creating nationwide uncertainty about legality.

    The ruling directly affects the distribution of mifepristone, Danco’s primary product.

    Mifepristone is one of two drugs commonly used in medication abortions.

    The application was directed to Justice Samuel Alito, who handles emergency matters from the 5th Circuit and can either act on his own or refer the request to the full court. The Supreme Court could act at any time.

    ABORTION PILL MIFEPRISTONE SPARKS NEW PRO-LIFE DEBATE AS SOME DOCTORS STRESS SAFETY CONCERNS

    Boxes of Mifepristone medication in a container at Alamo Women's Clinic in Carbondale, Ill.

    Boxes of mifepristone, a pill used for medical abortions. (Evelyn Hockstein/Reuters, File)

    In its filing, Danco warned the appeals court’s order is already creating “chaos” in real-world medical settings.

    “The panel’s ruling injects immediate confusion and upheaval into highly time-sensitive medical decisions,” the company wrote, adding it is forcing “providers, patients, and pharmacies all to guess at what is allowed and what is not.”

    The filing raises immediate questions, including what happens to existing abortion pill prescriptions, pharmacy dispensing and access to in-person visits.

    PRO-LIFE GROUP FINDS BIDEN-ERA FDA POLICY IS DRIVING 500 ABORTIONS PER DAY, SAYS TRUMP HAS POWER TO END IT

    Anti-abortion demonstrators holding a banner in front of the U.S. Supreme Court building in Washington, D.C.

    Pro-life demonstrators hold a banner in front of the U.S. Supreme Court building during the annual March for Life rally in Washington, D.C. (Evelyn Hockstein/Reuters, File)

    “What happens when patients arrive for scheduled appointments this weekend… or walk into pharmacies… to obtain [the drug] that was prescribed… yesterday?” the filing states.

    Danco is asking the court to immediately pause the ruling through an administrative stay, then block it longer term while litigation continues. The company also suggested the justices could take up the case on an expedited schedule before the end of the term, a move that could reshape the court’s already packed 2026 docket.

    The emergency appeal comes just one day after the 5th Circuit issued its ruling, which blocked the mailing of mifepristone and effectively barred pharmacy distribution under the challenged FDA rules, requiring women to obtain the drug in-person from a medical provider.

    PRO-LIFE MOVEMENT CONFRONTS HIGH ABORTION RATES THREE YEARS AFTER DOBBS

    An advertisement promoting abortion pills mifepristone and misoprostol in Florida

    An advertisement promoting the abortion pills mifepristone and misoprostol in Florida. (40 Days for Life)

    “Of course they filed an emergency petition. Big Pharma has gotten extremely rich after the unprecedented and radical deregulation of these dangerous abortion pills,” 40 Days for Life President Shawn Carney told Fox News Digital.

    “No abortion advocate or anyone from Big Pharma was pushing to send these drugs through the mail just a few years ago, and now they act as if they’re entitled to do so with zero regulation and zero oversight,” Carney added. “This is more evidence the FDA needs to reevaluate how these drugs were approved after years of ER visits from women who take them.”

    Abortion-rights advocates said the ruling has “upended” access to care nationwide, particularly for patients relying on telemedicine, while legal groups warned it is creating confusion for providers trying to comply with rapidly changing rules.

    New York Attorney General Letitia James said the decision is “yet another cruel attack on abortion access,” adding that “mifepristone is safe, effective, and essential.”

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    The underlying case is still ongoing in lower courts, but the emergency filing now places the dispute squarely before the Supreme Court in what could become the next major legal showdown over abortion policy.

    The justices could choose to pause the ruling immediately, allowing the current system to remain in place while the case proceeds, or let the restrictions take effect nationwide.

    Danco Laboratories did not immediately respond to Fox News Digital’s request for comment.

    Jasmine Baehr is a Breaking News Writer for Fox News Digital, where she covers politics, the military, faith and culture.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    Trump threatens to tug US troops from Italy and Spain over Iran entry | Invesloan.com

    Pro-energy group asks Congress to probe information heart opposition funding | Invesloan.com

    NYC units apart $500K for reparations talks amid $5.4B funds deficit | Invesloan.com

    No Kings Democrats mocked for cheering King Charles at Congress handle | Invesloan.com

    Bipartisan invoice seeks to dam China, Qatar funding to US universities | Invesloan.com

    A behind-the-scenes take a look at the famed Churchill Downs on Kentucky Derby day | Invesloan.com

    Trump teases US shall be ‘taking on’ Cuba ‘virtually instantly’ | Invesloan.com

    Pentagon withdraws 5,000 troops from Germany amid Trump-Merz feud | Invesloan.com

    US says Iran ceasefire resets warfare powers clock amid authorized dispute | Invesloan.com

    LATEST NEWS

    16 of 23 REIT shares beat Wall Street income views this week: Earnings Scorecard | Invesloan.com

    May 2, 2026

    XRP Price Analysis: Buy Now or Wait for Ripple to Fall Below $1? | Invesloan.com

    May 2, 2026

    ‘We’re all nervous the honey pot will run dry’: Does the U.S. authorities borrow from my Social Security to fund federal packages? | Invesloan.com

    May 2, 2026

    Warren Buffett says it's necessary to know which offers to not take | Invesloan.com

    May 2, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}